World

British regulators identify more blood clot cases after AstraZeneca vaccine, bringing total to 30

British regulators on Thursday said they have identified 30 cases of rare blood clot events after the use of the AstraZeneca-Oxford COVID-19 vaccine, 25 more than the agency previously reported.

Britain has administered more than 18.1 million doses of the COVID-19 vaccine so far

A vial of the AstraZeneca-Oxford COVID-19 vaccine is seen in Luton, England, on March 21. (Alberto Pezzali/The Associated Press)

British regulators on Thursday said they have identified 30 cases of rare blood clot events after the use of the AstraZeneca-Oxford COVID-19 vaccine, 25 more than the agency previously reported.

The Medicines and Healthcare products Regulatory Agency said it had received no such reports of clotting events following use of the vaccine made by BioNTech SE and Pfizer Inc.

The health officials said they still believe the benefits of the vaccine in the prevention of COVID-19 far outweigh any possible risk of blood clots.

Some countries are restricting use of the AstraZeneca vaccine while others have resumed inoculations, as investigations into reports of rare, and sometimes severe, blood clots continue.

On March 18, the U.K.'s medicines regulator said that there had been five cases of a rare brain blood clot among 11 million administered shots.

WATCH | Should people who've had the AstraZeneca vaccine be concerned?

COVID-19: Should people who’ve had the AstraZeneca vaccine be concerned?

The National

1 month ago
4:22
Infectious disease experts take questions about the changing advice for the AstraZeneca COVID-19 vaccine including if those who’ve had a shot should be concerned. 4:22

On Thursday, it put the count at 22 reports of cerebral venous sinus thrombosis, an extremely rare brain clotting ailment, and eight reports of other clotting events associated with low blood platelets out of a total of 18.1 million doses given.

In Canada, the National Advisory Committee on Immunization recommended on Monday that the use of the AstraZeneca vaccine for Canadians under 55 be immediately suspended.

Add some “good” to your morning and evening.

A variety of newsletters you'll love, delivered straight to you.

Sign up now

Comments

To encourage thoughtful and respectful conversations, first and last names will appear with each submission to CBC/Radio-Canada's online communities (except in children and youth-oriented communities). Pseudonyms will no longer be permitted.

By submitting a comment, you accept that CBC has the right to reproduce and publish that comment in whole or in part, in any manner CBC chooses. Please note that CBC does not endorse the opinions expressed in comments. Comments on this story are moderated according to our Submission Guidelines. Comments are welcome while open. We reserve the right to close comments at any time.

Become a CBC Member

Join the conversationCreate account

Already have an account?

now